The USFDA conducted an inspection at the group's transdermal manufacturing site located at SEZ in Ahmedabad. The inspection was conducted from July 15 to 19, 2024.
The inspection closed with 2 observations. The Company is confident of addressing the issues raised by the USFDA within the stipulated timeline, and is committed to resolving the same at the earliest.
Shares of Zydus Lifesciences Limited was last trading in BSE at Rs. 1144.60 as compared to the previous close of Rs. 1185.30. The total number of shares traded during the day was 105145 in over 4403 trades.
The stock hit an intraday high of Rs. 1168.75 and intraday low of 1137.90. The net turnover during the day was Rs. 121895208.00. |
